November 13, 2013
, a world-leading provider of scientific, technical and medical information products and services, announces the launch of
, the first full open access journal within the
Biochimica et Biophysica Acta (BBA)
will focus on translating molecular insights into clinical research.
is a biomedical journal dedicated to publishing research on the molecular basis of human diseases, as well as presenting findings from clinical trials that target biochemical pathways and processes. All articles in
describe, in part or entirely, studies using human patient samples or human cohorts. Clinical areas of particular interest include aging, cancer, cardiovascular-, metabolic-, neurological-, and immunological diseases; the interactions that may occur among these different diseases and conditions; and studies that examine their early or pre-symptomatic states. Cross-sectional and prospective studies from well-established cohorts, and studies involving imaging methodologies, are particularly encouraged for submission.
"The journal provides a new forum for insights concerning the biochemical mechanisms related to diagnosis, progression, and treatment of a wide range of human diseases," said
Jeffrey N. Keller
from Pennington Biomedical Research Center,
Baton Rouge, Louisiana
will offer not just a useful forum for clinical research today, but it is designed to be a prominent contributor to the larger overall body of clinical advancements far into the future."
"We are very excited about the launch of
added Dolors Alsina, Executive Publisher at Elsevier. "The journal will build on our long standing track record as one of the leading international journals focusing on molecular aspects in biology and medicine and will break new ground as the clinical complement to
BBA Molecular Basis of Disease.
For more information or to submit an article, go to
About Open Access Publishing at Elsevier